Diclofenac Sodium CAS 15307-79-6: Comprehensive Guide for Buyers and Researchers
Table of Contents
- 1. Product Overview & Specifications
- 2. Key Applications & Industrial Uses
- 3. Comparative Analysis with Similar NSAIDs
- 4. Usage Guidelines & Safety Protocols
- 5. Verified Case Studies
- 6. Procurement Support & Inquiry
1. Product Overview & Specifications
| Parameter | Diclofenac Sodium CAS 15307-79-6 |
|---|---|
| CAS Number | 15307-79-6 |
| Molecular Formula | C14H10Cl2NNaO2 |
| Purity Grade | Pharmaceutical (≥99%), Industrial (95-98%) |
| Appearance | White to off-white crystalline powder |
| Solubility | Freely soluble in water, methanol; slightly soluble in ethanol |
| Storage | 2-8°C in airtight containers |
2. Key Applications & Industrial Uses
Medical Applications
- Osteoarthritis/Rheumatoid Arthritis Management
- Acute Musculoskeletal Pain Relief
- Postoperative Inflammation Control
- Migraine Treatment Formulations
Non-Medical Uses
- Veterinary Anti-inflammatory Preparations
- Research Chemical in COX Inhibition Studies
- Intermediate for Advanced Drug Synthesis
3. Comparative Analysis with Similar NSAIDs
| Feature | Diclofenac Sodium | Ibuprofen | Naproxen |
|---|---|---|---|
| Potency (COX-2 Inhibition) | High | Moderate | Moderate |
| Dosing Frequency | 2-3 times daily | 4-6 times daily | 2 times daily |
| Topical Formulation Availability | Gel, Patch, Spray | Limited | Cream Only |
4. Usage Guidelines & Safety Protocols
Dosage Recommendations
- Oral Tablets: 50-150 mg/day divided doses
- Topical Gel: 4g/application (4% concentration)
- IV Injection: 75 mg every 12 hours
Critical Handling Notes
- Use PPE during bulk processing
- Avoid concurrent use with ACE inhibitors
- Monitor renal function in long-term use
5. Verified Case Studies
Case 1: Pharmaceutical Manufacturer (India)
- Application: Osteoarthritis gel production
- Volume: 800 kg/year
- Outcome: 40% pain reduction in clinical trials
Case 2: Research Institute (Germany)
- Application: COX-2 selectivity studies
- Material Grade: Analytical Standard (99.8%)
- Result: Published in Eur J Pharmacol (2023)
Case 3: Veterinary Supplier (USA)
- Application: Equine anti-inflammatory injections
- Formulation: 10% solution for intramuscular use
- Feedback: 92% efficacy in racehorse recovery
6. Procurement Support & Inquiry
For technical specifications sheets or bulk pricing:
- Email: info@vivalr.com
- Phone: (86) 15866781826
Request free samples (GMP-certified batches available)



评论
目前还没有评论。